About AMAG Pharma
AMAG Pharma is a company based in Waltham (United States) founded in 1981 was acquired by Covis Pharma in October 2020. AMAG Pharma has completed 4 acquisitions, including Cord Blood Registry, Lumara Health and Perosphere. AMAG Pharma offers products and services including Alvesco and Feraheme.
- Headquarter Waltham, United States
- Stage Public
-
Sectors
Healthcare
-
Phone
Locked
-
Website
Locked
-
Social
Locked
- Legal Name Covis Pharma Gmbh
-
Annual Revenue
Not available
-
Net Profit
Not available
-
EBITDA
Not available
-
Latest Funding Round
Not available
- Investors
-
Employee Count
Not available
-
Investments & Acquisitions
Cord Blood Registry
& 3 more
-
Acquired by
Covis Pharma
(Oct 01, 2020)
Unlock complete access to The Company Check
Get unrestricted viewing across everything we track — from companies and brands to investors, funding rounds, acquisitions, financials, and more.
- Unlimited viewing on all profiles Companies, investors, financials, funding, acquisitions & directors
- Full access to every database India & global coverage, advanced filters and rich profile details
- Always-on access from your team account Single premium plan for everything you see on the portal
Products & Services of AMAG Pharma
AMAG Pharma offers a comprehensive portfolio of products and services, including Alvesco and Feraheme.
Alvesco is utilized for the treatment of asthma and other respiratory conditions in patients.
Feraheme is employed for addressing iron deficiency anemia in adult patients with chronic kidney disease.
People of AMAG Pharma
Unlock access to complete
Funding Insights of AMAG Pharma
Detailed funding history for AMAG Pharma
Round names, dates, amounts, investors, and valuation history require an active premium plan.
- Round names and dates
- Funding amounts
- Participating investors
- Valuation history
Verified entity values are shown only after access is granted.
Investors in AMAG Pharma
AMAG Pharma has secured backing from 1 investor. Prominent investors backing the company include Covis Pharma.
| Investor | Description | Founded Year | Domain | Location |
|---|---|---|---|---|
|
Pharmaceutical company that markets therapeutic solutions for patients with life-threatening conditions and chronic illnesses
|
Locked | Locked | Locked |
Investor details for AMAG Pharma
Investor domains, locations, round participation, and complete history require an active premium plan.
- Investor domains
- Investor locations
- Funding rounds
- Participation history
Verified entity values are shown only after access is granted.
Investments & Acquisitions by AMAG Pharma
AMAG Pharma has strategically engaged in corporate development activities, having acquired 4 companies. Notable acquisitions include Cord Blood Registry, Lumara Health and Perosphere.
Investment portfolio details for AMAG Pharma
Portfolio company identities, transaction dates, round details, and investment values require an active premium plan.
- Portfolio identities
- Transaction dates
- Round details
- Investment values
Verified entity values are shown only after access is granted.
| Company Name | Description | Domain | Location | Founded Year | Amount |
|---|---|---|---|---|---|
|
Anticoagulant reversal agent and small molecules to prevent allergic reactions, traumatic brain injury.
|
Locked | Locked | 2011 | Locked | |
|
Novel small molecule agents for anticoagulant reversal are developed.
|
Locked | Locked | 2011 | Locked | |
|
Cord blood and tissue stem cells are collected and preserved.
|
Locked | Locked | 1992 | Locked |
Complete acquisition details for AMAG Pharma
Transaction dates, acquired stakes, disclosed values, domains, and locations require an active premium plan.
- Transaction dates
- Acquired stakes
- Disclosed values
- Domains and locations
Verified entity values are shown only after access is granted.
Financial Statements - AMAG Pharma
Detailed financials for AMAG Pharma
Historical revenue, profit, statement rows, ratios, and trend charts require an active premium plan.
- Historical revenue
- Profit trends
- Statement rows
- Financial ratios
Verified entity values are shown only after access is granted.
Amag Pharma Comparisons
Peer comparison for AMAG Pharma
Named peer metrics, headcount, funding, location, and side-by-side benchmarks require an active premium plan.
- Named peers
- Headcount comparison
- Funding comparison
- Operating benchmarks
Verified entity values are shown only after access is granted.
Competitors of AMAG Pharma
Detailed competitors of AMAG Pharma
Competitor domains, locations, full profiles, and operating metrics require an active premium plan.
- Domains and locations
- Full company profiles
- Operating metrics
- Competitive positioning
Verified entity values are shown only after access is granted.
Latest news on Amag Pharma
Complete news archive for AMAG Pharma
Full article history, source details, and older brand coverage require an active premium plan.
- Full article archive
- Source and publication date
- Older coverage
- Brand-specific news history
Verified entity values are shown only after access is granted.
Frequently Asked Questions about AMAG Pharma
AMAG Pharma was founded in 1981.
AMAG Pharma is headquartered in Waltham, United States. It is registered at Waltham, Massachusetts, United States.
AMAG Pharma was founded in 1981 and is headquartered in Waltham, United States. Operations focus on the pharmaceutical sector, where anemia-based products and diagnostic imaging agents are developed and commercialized. A therapeutic iron compound is produced to address iron deficiency anemia, alongside agents for cancer and cardiovascular disease diagnosis. Two approved products, Feraheme injection for intravenous use and GastroMARK, are manufactured and distributed.
AMAG Pharma offers Alvesco and Feraheme.
AMAG Pharma has made 4 acquisitions, including Cord Blood Registry, Lumara Health, and Perosphere.
AMAG Pharma has 1 investor. Key investors include Covis Pharma.